Liquidia (LQDA) Stock: Buy, Sell, or Hold?
LQDA - Liquidia Corporation Common Stock
$27.99
-2.27 (-7.50%)
▼
5d:
-60.55%
30d:
-58.17%
90d:
-64.54%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 02, 2026
30d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Sep 29, 2026 at $69.12 · last confirmed Oct 1, 2026
Strength: 7.2/10
Get Alerted When LQDA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: LQDA is down 60.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: LQDA is down 60.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$132.03
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$81.98
65.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LQDA is currently trading at $27.99, which is considered oversold relative to its 30-day fair value range of $55.47 to $76.14. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.0) compared to its historical average (12.0). Remarkably, the market is currently pricing in an annual earnings decline of 25.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, LQDA is showing sideways momentum. Immediate support is located at $22.31, while resistance sits at $74.74. Short-term momentum is weak, with the stock down 7.5% recently.
Market Sentiment: LQDA scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $107.75 (+285.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LQDA is showing sideways momentum. Immediate support is located at $22.31, while resistance sits at $74.74. Short-term momentum is weak, with the stock down 7.5% recently.
Market Sentiment: LQDA scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $107.75 (+285.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$55.47 -
$76.14
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
Protect Your Profits
Holding LQDA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.5%)
- BULLISH: Trading 285.0% below Wall St target ($107.75)
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$55.47 -
$76.14
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$22.31
Resistance Level
$74.74
Current Trend
Sideways
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
4.95
Wall Street Target
$107.75
(+285.0%)
Revenue Growth (YoY)
1842.7%
Profit Margin
30.7%
Valuation Discount vs History
-25.6% cheaper
PE vs Historical
5.0 vs 12.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-25.6%
(market-implied from PE analysis)
1-Year Target
$25.19
(-10%)
2-Year Target
$22.67
(-19%)
3-Year Target
$20.40
(-27%)
3-Yr Target (if PE normalizes)
(PE: 5→12)
$49.43
(+77%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 75.5%)
$389.00
(+1290%)
Base:
(SPY PE: 5.0, Growth: 75.5%)
$94.47
(+238%)
Bear:
(PE: 4.2, Growth: 75.5%)
$80.30
(+187%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (9x PE), but valuation improves significantly next year (5x PE) as earnings recover.
Trailing PE: 9.23 | Current EPS (TTM): $3.28
Bull Case
$57.34
(+105%)
Analyst growth 72.3%, PE expands to 10.2
Base Case
$52.12
(+86%)
Market implied 72.3%, PE stable at 9.2
Bear Case
$20.58
(-27%)
Severe decline -20.0%, PE contracts to 7.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.0 to 12.0
Stabilization Target:
$67.80
(+142.2%)
PE Expansion Potential:
+142.2%
Share & Embed Analysis
Last updated: October 01, 2026 8:36 PM ET
Data refreshes hourly during market hours. Next update: 9:36 PM
Data refreshes hourly during market hours. Next update: 9:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LQDA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
17
Sells
Net
INSIDERS SELLING
Recent Transactions
Roger Jeffs
SELL
18839 shares
2026-04-17
Michael Kaseta
SELL
139390 shares
2026-04-15
Roger Jeffs
SELL
25000 shares
2026-04-15
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$208 | 54 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$96 | 58 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$108 | 55 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 62 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 53 HOLD |
Advanced LQDA Option Strategies
Professional options setups generated by AI based on today's LQDA price and gamma walls.